Closing The Books On Purdue – And US FDA’s Policies To Control Opioids

A massive settlement of opioid litigation is intended to end the era of opioid marketing defined by OxyContin. It also like closes the books on efforts to rely on the US FDA to control the prescription abuse crisis.

old books on the shelf - Image
What will the history books say about the US FDA's risk management plans for opioids?

There is very little reference to the US Food & Drug Administration in the settlement documents released by the Department of Justice in its resolution of opioid litigation with Purdue Pharma L.P.

There is just one reference in the context of one of the criminal counts against Purdue: “Purdue knowingly and intentionally...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet